Could new tracer spare breast cancer patients unnecessary surgery?
NCT ID NCT06868238
Summary
This study aimed to test a new iron-based tracer called Magtrace. The goal was to see if it could help patients with a very early form of breast cancer (DCIS) avoid having lymph nodes removed during their mastectomy surgery. If invasive cancer was later found in the breast tissue, the tracer would still be present, allowing doctors to perform the lymph node surgery later if truly needed.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DUCTAL CARCINOMA IN SITU are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Florida
Gainesville, Florida, 32608, United States
Conditions
Explore the condition pages connected to this study.